Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings Inc (XTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 98,353
  • Shares Outstanding, K 140,004
  • Annual Sales, $ 117,270 K
  • Annual Income, $ -16,450 K
  • EBIT $ 6 M
  • EBITDA $ 11 M
  • 60-Month Beta -0.05
  • Price/Sales 0.88
  • Price/Cash Flow N/A
  • Price/Book 2.06
  • Price/Earnings ttm 74.00
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings $0.01 on 11/10/25
  • Next Earnings Date 03/05/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +249,850.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5611 +23.85%
on 11/28/25
0.8100 -14.21%
on 11/12/25
-0.0614 (-8.12%)
since 11/11/25
3-Month
0.5473 +26.97%
on 09/19/25
0.9500 -26.85%
on 10/31/25
+0.0738 (+11.88%)
since 09/11/25
52-Week
0.3310 +109.94%
on 12/16/24
0.9500 -26.85%
on 10/31/25
+0.3119 (+81.44%)
since 12/11/24

Most Recent Stories

More News
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strataâ„¢ Synthetic Bone Graft

nanOss Strataâ„¢ is designed to more closely mimic the structure of human bone, increase the graft's surface area, improve osteoconductivity and enhance the stimulation of cellular activity

XTNT : 0.6949 (-1.08%)
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine

BELGRADE, Mont. , Dec. 1, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic...

XTNT : 0.6949 (-1.08%)
Xtant Medical Reports Third Quarter 2025 Financial Results

Total Revenue of $33.3 Million Increased 19% Year-over-Year

XTNT : 0.6949 (-1.08%)
Xtant Medical Announces Commercial Launch of CollagenXâ„¢

Launch further expands Xtant's biologics product portfolio to include surgical wound closure

XTNT : 0.6949 (-1.08%)
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025

BELGRADE, Mont. , Nov. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal,...

XTNT : 0.6949 (-1.08%)
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

BELGRADE, Mont. , Sept. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc.  (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment...

XTNT : 0.6949 (-1.08%)
Xtant Medical Reports Second Quarter 2025 Financial Results

Total Revenue of $35.4 Million Increased 18% Year-over-Year

XTNT : 0.6949 (-1.08%)
Xtant Medical to Attend the CG 45th Annual Growth Conference

BELGRADE, Mont. , Aug. 6, 2025 /PRNewswire/ --  Xtant Medical Holdings, Inc.  (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment...

XTNT : 0.6949 (-1.08%)
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025

BELGRADE, Mont. , Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment...

XTNT : 0.6949 (-1.08%)
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Full Year 2024 Revenue Growth of 28%

XTNT : 0.6949 (-1.08%)

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Key Turning Points

3rd Resistance Point 0.8135
2nd Resistance Point 0.7913
1st Resistance Point 0.7469
Last Price 0.6949
1st Support Level 0.6803
2nd Support Level 0.6581
3rd Support Level 0.6137

See More

52-Week High 0.9500
Fibonacci 61.8% 0.7135
Last Price 0.6949
Fibonacci 50% 0.6405
Fibonacci 38.2% 0.5675
52-Week Low 0.3310

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar